Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Northwest Biotherapeutics Inc.
DescriptionAutologous dendritic cells treated ex vivo with patient-specific tumor lysates
Molecular Target
Mechanism of Action 
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I/II
Standard IndicationPancreatic cancer
Indication DetailsTreat pancreatic cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today